During the past decade, Sunderland Royal Hospital conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 8 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sunderland Royal Hospital" #1 sponsor was "Newcastle-upon-Tyne Hospitals NHS Trust" with 3 trials, followed by "University College, London" with 3 trials sponsored, "University of Edinburgh" with 3 trials sponsored, "University of Oxford" with 3 trials sponsored and "City Hospitals Sunderland NHS Foundation Trust" with 3 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sunderland Royal Hospital" #1 collaborator was "Cancer Research UK" with 6 trials as a collaborator, "Takeda" with 3 trials as a collaborator, "London School of Hygiene and Tropical Medicine" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator and "NHS Lothian" with 2 trials as a collaborator. Other collaborators include 52 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "Sunderland Royal Hospital" are "Sepsis" (5 trials), "Prostate Cancer" (4 trials), "Critical Illness" (3 trials), "Lymphoma" (3 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Sunderland Royal Hospital" in a lesser frequency.

Most popular intervention types in "Sunderland Royal Hospital" are "Drug" (29 trials), "Other" (12 trials), "Procedure" (12 trials), "Biological" (8 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "capecitabine" (3 trials), "cyclophosphamide" (3 trials), "Cyclophosphamide" (2 trials) and "Epacadostat" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sunderland Royal Hospital" are 43 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Sunderland Royal Hospital". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 31 completed trials in Sunderland Royal Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sunderland Royal Hospital, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 13 trials that are defined as “Not Applicable".